Jamal Ahmad Ibdah MD PhD
Professor, Internal Medicine, University of Missouri, Columbia School of Medicine
Join to View Full Profile
101 S Fairview RdColumbia, MO 65203
Phone+1 573-884-7600
Fax+1 573-884-8200
Dr. Ibdah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1994 - 1997
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Jordan Faculty of MedicineClass of 1982
Certifications & Licensure
MO State Medical License 2005 - 2026
NC State Medical License 1997 - 2025
UT State Medical License 1993 - 1994
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (FACG) American College of Gastroenterology
- Fellow (FAASLD) American Association for the Study of Liver Diseases
- Fellow (AGAF) American Gastroenterological Association
Clinical Trials
- Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease Start of enrollment: 2010 Oct 01
- The Liver Health Study for Patients with NAFLD Start of enrollment: 2017 Aug 09
Publications & Presentations
PubMed
- 6 citationsHistological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH.Justine M Mucinski, Amadeo F Salvador, Mary P Moore, Talyia M Fordham, Jennifer M Anderson
Journal of Hepatology. 2024-11-01 - 4 citationsRelationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.Mary P Moore, Grace Shryack, Isabella Alessi, Nicole Wieschhaus, Grace M Meers
American Journal of Physiology. Endocrinology and Metabolism. 2024-04-01 - 4 citationsHepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development.Ryan J Dashek, Rory P Cunningham, Christopher L Taylor, Isabella Alessi, Connor Diaz
Cellular and Molecular Gastroenterology and Hepatology. 2024-01-01
Press Mentions
New Study Shows Diet, Exercise Reverses Liver DamageOctober 12th, 2024
Gallbladder Cancer Rates Decreasing in Men, Not Women; Late-Stage Diagnosis on the RiseApril 24th, 2017
Corrigendum: Outcomes ResearchJanuary 10th, 2017- Join now to see all
Grant Support
- Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)HARRY S. TRUMAN MEMORIAL VA HOSPITAL2023–2029
- Beta-Oxidation And Susceptibility To Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2008
- CTSA Planning Project:Mu Institute For ClinicalNational Center For Research Resources2006
- CTSA Planning Project: MU Institute For Clinical And Translational ScienceNational Center For Research Resources2006
- Maternal Liver Disease And Fatty Acid Oxidation DefectsNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Liver Disease And Fatty Oxidation DisordersNational Center For Research Resources2004–2005
- Maternal Liver Disease And Fatty Acid Oxidation DefectsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- Molecular Analysis Of Fatty Acid Oxidation DefectNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2001
- Effects Of High Fat Diet On Heterozygotes W/ Mutations In Fatty AcidNational Center For Research Resources2000
- Molecular Analysis Of Fatty Acid Oxidation DefectNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
